Diabetic macular edema is a serious complication associated with diabetic retinopathy, the most common diabetic eye disease. In the advanced stages of diabetic retinopathy, some patients’ blood vessels may swell and leak fluid into the macula, the part of the eye responsible for central high-resolution vision. This condition is called diabetic macular edema and is the most common cause of visual loss in diabetic retinopathy. It may even cause blindness if left untreated. Teprotumumab is being investigated in a Phase I study to treat diabetic macular edema. For more information on studies of teprotumumab, visit clinicaltrials.gov.
Back to top